by Staff | Nov 13, 2024 | Press Releases
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol “IZTC” Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially...
by Staff | Nov 12, 2024 | Press Releases
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol “IZTC” Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) — Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially...
by Staff | Oct 24, 2024 | Press Releases
Company Receives Top Honors in the ‘Home Health Diagnostic’ Category for its Groundbreaking Technology that Captures the Heart’s Electrical Signals from Three Dimensions SANTA CLARA, Calif.–(BUSINESS WIRE)– HeartBeam, Inc. (NASDAQ: BEAT), a medical...
by Staff | Oct 16, 2024 | Press Releases
Addison, TX, Oct. 16, 2024 (GLOBE NEWSWIRE) — MDB Capital Holdings, LLC (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, announced its sponsorship of TCA Venture Group,...
by Staff | Jul 17, 2024 | Press Releases
Project Comprised of 26 ClearSign Core™ Process Burners in Four Heaters Order Received from Birwelco USA Inc. for Fortune 500 Global Chemical Company TULSA, Okla., July 17, 2024 /PRNewswire/ — ClearSign Technologies Corporation (Nasdaq: CLIR)...
Recent Comments